JP2022523045A5 - - Google Patents
Info
- Publication number
- JP2022523045A5 JP2022523045A5 JP2021543165A JP2021543165A JP2022523045A5 JP 2022523045 A5 JP2022523045 A5 JP 2022523045A5 JP 2021543165 A JP2021543165 A JP 2021543165A JP 2021543165 A JP2021543165 A JP 2021543165A JP 2022523045 A5 JP2022523045 A5 JP 2022523045A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797854P | 2019-01-28 | 2019-01-28 | |
| US62/797,854 | 2019-01-28 | ||
| PCT/US2020/014953 WO2020159822A1 (en) | 2019-01-28 | 2020-01-24 | Methods of treating breast cancer with tucatinib |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523045A JP2022523045A (ja) | 2022-04-21 |
| JP2022523045A5 true JP2022523045A5 (https=) | 2023-02-02 |
| JPWO2020159822A5 JPWO2020159822A5 (https=) | 2023-02-02 |
Family
ID=69740562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543165A Pending JP2022523045A (ja) | 2019-01-28 | 2020-01-24 | ツカチニブを用いて乳がんを処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220193076A1 (https=) |
| EP (1) | EP3917533A1 (https=) |
| JP (1) | JP2022523045A (https=) |
| KR (1) | KR20210119498A (https=) |
| CN (1) | CN113613656A (https=) |
| AR (1) | AR119681A1 (https=) |
| AU (1) | AU2020215551A1 (https=) |
| CA (1) | CA3126279A1 (https=) |
| IL (1) | IL284850A (https=) |
| MX (1) | MX2021008834A (https=) |
| SG (1) | SG11202107488PA (https=) |
| TW (1) | TW202042820A (https=) |
| WO (1) | WO2020159822A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3060407A1 (en) | 2017-04-28 | 2018-11-01 | Seattle Genetics, Inc. | Treatment of her2 positive cancers |
| US20220125877A1 (en) * | 2019-07-10 | 2022-04-28 | Sun Yat-Sen University | Method for treating colorectal cancer |
| US20230372342A1 (en) * | 2020-09-28 | 2023-11-23 | Seagen Inc. | Methods of treating solid tumors driven by her2 alterations with tucatinib in combination with an anti-her2 antibody |
| AU2022238571A1 (en) | 2021-03-18 | 2023-09-14 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| CN117243959B (zh) * | 2022-10-13 | 2026-03-06 | 山东大学 | 治疗骨质疏松的方法和药物组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
| US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
| US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| US5268164A (en) | 1990-04-23 | 1993-12-07 | Alkermes, Inc. | Increasing blood-brain barrier permeability with permeabilizer peptides |
| US5254342A (en) | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
| AU668384B2 (en) | 1992-03-12 | 1996-05-02 | Alkermes Controlled Therapeutics, Inc. | Controlled release ACTH containing microspheres |
| US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| CA3060407A1 (en) * | 2017-04-28 | 2018-11-01 | Seattle Genetics, Inc. | Treatment of her2 positive cancers |
-
2020
- 2020-01-21 TW TW109102121A patent/TW202042820A/zh unknown
- 2020-01-24 JP JP2021543165A patent/JP2022523045A/ja active Pending
- 2020-01-24 EP EP20708761.0A patent/EP3917533A1/en not_active Withdrawn
- 2020-01-24 MX MX2021008834A patent/MX2021008834A/es unknown
- 2020-01-24 KR KR1020217027147A patent/KR20210119498A/ko not_active Withdrawn
- 2020-01-24 US US17/310,212 patent/US20220193076A1/en not_active Abandoned
- 2020-01-24 WO PCT/US2020/014953 patent/WO2020159822A1/en not_active Ceased
- 2020-01-24 CN CN202080022864.7A patent/CN113613656A/zh active Pending
- 2020-01-24 AU AU2020215551A patent/AU2020215551A1/en not_active Abandoned
- 2020-01-24 SG SG11202107488PA patent/SG11202107488PA/en unknown
- 2020-01-24 CA CA3126279A patent/CA3126279A1/en active Pending
- 2020-01-27 AR ARP200100202A patent/AR119681A1/es not_active Application Discontinuation
-
2021
- 2021-07-14 IL IL284850A patent/IL284850A/en unknown